Medicine and Dentistry

1. Patient 100%
2. Non Small Cell Lung Cancer 67%
3. Malignant Neoplasm 49%
4. Technetium-99 41%
5. Therapeutic Procedure 39%
6. Programmed Death 1 Ligand 1 39%
7. Programmed Death-Ligand 1 32%
8. Nanobody 27%
9. COVID-19 25%
10. Biological Marker 23%
11. Fluorodeoxyglucose F 18 23%
12. Positron Emission Tomography-Computed Tomography 22%
13. Neoplasm 22%
14. Single Photon Emission Computed Tomography-Computed Tomography 20%
15. Chemotherapy 20%
16. Age 19%
17. Primary Tumor 16%
18. Retrospective Study 14%
19. Single-Photon Emission Computed Tomography 14%
20. Lesion 13%
21. Patient with Cancer 13%
22. Attitude 13%
23. Oncologist 13%
24. Transgender 13%
25. Disease 9%
26. Oncology 9%
27. Prognosis 9%
28. Fluorodeoxyglucose 8%
29. Immunity 7%
30. Metabolism 7%
31. Fluorine-18 7%
32. Targeted Therapy 7%
33. Diagnosis 6%
34. Prospective Cohort Study 6%
35. Cancer Epidemiology 6%
36. Coronavirinae 6%
37. Lung Cancer 6%
38. Hematologic Malignancy 6%
39. COVID-19 Mortality 6%
40. Venous Thromboembolism 6%
41. Neoadjuvant Chemotherapy 6%
42. Meta-Analysis 6%
43. Woman 6%
44. Ovarian Cancer 6%
45. Cytoreductive Surgery 6%
46. Systematic Review 6%
47. Healthcare Research 6%
48. Cancer in Young Adults 6%
49. Older Adult 6%
50. Gastrointestinal Toxicity 6%